AWM Capital LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 16.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 449 shares of the healthcare conglomerate’s stock after buying an additional 65 shares during the period. AWM Capital LLC’s holdings in UnitedHealth Group were worth $227,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in UNH. Proficio Capital Partners LLC boosted its holdings in UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares during the period. Oppenheimer & Co. Inc. grew its stake in shares of UnitedHealth Group by 1.4% in the fourth quarter. Oppenheimer & Co. Inc. now owns 59,320 shares of the healthcare conglomerate’s stock worth $30,008,000 after acquiring an additional 830 shares during the last quarter. Kovack Advisors Inc. grew its position in UnitedHealth Group by 53.5% in the 4th quarter. Kovack Advisors Inc. now owns 10,276 shares of the healthcare conglomerate’s stock worth $5,198,000 after purchasing an additional 3,581 shares during the last quarter. Mn Services Vermogensbeheer B.V. lifted its stake in shares of UnitedHealth Group by 2.1% in the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 365,300 shares of the healthcare conglomerate’s stock valued at $184,791,000 after buying an additional 7,500 shares during the period. Finally, K.J. Harrison & Partners Inc boosted its position in shares of UnitedHealth Group by 1.4% during the 4th quarter. K.J. Harrison & Partners Inc now owns 1,855 shares of the healthcare conglomerate’s stock valued at $936,000 after acquiring an additional 25 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.
UnitedHealth Group Trading Down 1.4 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.81%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on UNH shares. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.
View Our Latest Stock Analysis on UnitedHealth Group
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- What is a Bond Market Holiday? How to Invest and Trade
- These Consumer Staples Shine Amid Market Turmoil
- Best Stocks Under $5.00
- Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
- Technology Stocks Explained: Here’s What to Know About Tech
- Axon: Long-Term Outlook Is Strong Despite Federal Budget Worries
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.